Neuropathological aspects of gaucher disease

Gaucher Disease

Volumn , Issue , 2006, Pages 225-248

  Wong, Kondi ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36849000942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420005509     Document Type: Chapter

References (73)

1. Brady, R.O., et al., Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher’s disease, J. Clin. Invest., 45, 1112, 1966.
2. Beutler, E. and G.A. Grabowski, Gaucher disease, in Metabolic & Molecular Basis of Inherited Disease, W.S. Sly, Ed., McGraw-Hill, New York, 2001, 3635.
3. Brady, R.O. and J.A. Barranger, Glucosylceramide lipidosis, in The Metabolic Basis of Inherited Disease, J.B. Stanbury, J.B. Wyngaarden, and D.S. Fredrickson, Eds., McGraw-Hill, New York, 1983, 842.
4. Ginns, E.I., et al., Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease, Proc. Natl. Acad. Sci. U.S.A., 79, 5607, 1982.
5. Ginns, E.I., et al., Determination of Gaucher’s disease phenotypes with monoclonal antibody, Clin. Chim. Acta. 131, 283, 1983.
6. Harris, C.M., et al., Auditory brainstem response and eye movement in diagnosis of Morbus Gaucher type 3, Monatsschrift Kinderheilkunde. 151, 854, 2003.
7. Brady, R.O., Sphingolipidoses, Ann. Rev. Biochem., 47, 687, 1978.
8. Miller, J.D., R. McCluer, and J.N. Kanfer, Gaucher’s disease: neurologic disorder in adult siblings, Ann. Intern. Med., 78, 883, 1973.
9. Vellodi, A., et al., Management of neuronopathic Gaucher disease: a European consensus, J. Inherit. Metab. Dis., 24, 319, 2001.
10. Niemann, A., Ein unbekanntes Krankheitsbild, Jahrb. f Kinderheilk, 1, 1914.
11. Gaucher, P.C.E., De L’epithelioma primitif de la rate hypertrophie idiopathique de la rate sans leucemie. Medicine, University of Paris, Paris, 1882.
12. Adachi, M., et al., Fine structure of central nervous system in early infantile Gaucher’s disease, Arch. Pathol., 83, 513, 1967.
13. Banker B.Q.M.J. and C.A.C., The cerebral pathology of infantile Gaucher’s Disease, Academic Press, New York, 1962, 73.
14. Norman, R.M. and O.C. Lloyd, The neuropathology of infantile Gaucher’s disease, J. Pathol. Bacteriol., 72, 1956.
15. Lee, R.E., The Pathology of Gaucher Disease, Alan R. Liss, New York, 1982, 177.
16. Kaye, E.M., et al., Type 2 and type 3 Gaucher disease: a morphological and biochemical study, Ann. Neurol., 20, 223, 1986.
17. Espinas, O.E. and A.A. Faris, Acute infantile Gaucher’s disease in identical twins. An account of clinical and neuropathologic observations, Neurology. 19, 133, 1969.
18. Wong, K., et al., Neuropathology provides clues to the pathophysiology of Gaucher disease, Mol. Genet. Metab., 82, 192, 2004.
19. Conradi, N., et al., Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings, Acta Neuropathol. (Berlin), 82, 152, 1991.
20. Conradi, N.G., et al., Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies, Acta Neuropathol. (Berlin), 65, 99, 1984.
21. Conradi, N.G., H. Kalimo, and P. Sourander, Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease, Acta Neuropathol. (Berlin), 75, 385, 1988.
22. Neil, J.F., R.H. Glew, and S.P. Peters, Familial psychosis and diverse neurologic abnormalities in adult-onset Gaucher’s disease, Arch. Neurol., 36, 95, 1979.
23. Soffer, D., et al., Central nervous system involvement in adult-onset Gaucher’s disease, Acta Neuropathol. (Berlin), 49, 1, 1980.
24. Van Bogaert, L.F., Un cas de maladie de Gaucher de l’adulte avec syndrome de Raynaud, pigmentation, et rigidite du type extra-pyrajidal aux membres inferieurs, Ann. Med., 45, 57, 1939.
25. McKeran, R.O., et al., Neurological involvement in type 1 (adult) Gaucher’s disease, J. Neurol. Neurosurg. Psych., 48, 172, 1985.
26. Neudorfer, O., et al., Occurrence of Parkinson’s syndrome in type I Gaucher disease, Qjm. 89, 691, 1996.
27. Machaczka, M., et al., Parkinson’s syndrome preceding clinical manifestation of Gaucher’s disease, Am. J. Hematol., 61, 216, 1999.
28. Varkonyi, J., et al., Gaucher disease associated with parkinsonism: four further case reports, Am. J. Med. Genet. A. 116, 348, 2003.
29. Tayebi, N., et al., Gaucher disease and parkinsonism: a phenotypic and genotypic characterization, Mol. Genet. Metab., 73, 313, 2001.
30. Sidransky, E., Gaucher disease: complexity in a “simple” disorder, Mol. Genet. Metab., 83, 6, 2004.
31. Aharon-Peretz, J., H. Rosenbaum, and R. Gershoni-Baruch, Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews, N. Engl. J. Med., 351, 1972, 2004.
32. Bembi, B., et al., Gaucher’s disease with Parkinson’s disease: clinical and pathological aspects, Neurology. 61, 99, 2003.
33. Tayebi, N., et al., Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol. Genet. Metab., 79, 104, 2003.
34. Lowe, J., Lewy Bodies, in Neurodegenerative Diseases, D.B. Calne, Ed., Saunders, Philadelphia, 1994, 51.
35. Grafe, M. et al., Infantile Gaucher disease: a case with heuronal storage, Ann. Neurol., 23, 300, 1988.
36. Lwin, A., et al., Glucocerebrosidase mutations in subjects with parkinsonism, Mol. Genet. Metab., 81, 70, 2004.
37. Goker-Alpan, O., et al., Parkinsonism among Gaucher disease carriers, J. Med. Genet., 41, 937, 2004.
38. Lloyd-Evans, E., et al., Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms, J. Biol. Chem., 278, 23594, 2003.
39. Verma, A., et al., Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain, Biochem. Biophys. Res. Commun., 172, 811, 1990.
40. Verma, A., et al., Rat brain endoplasmic reticulum calcium pools are anatomically and functionally segregated, Cell. Regul., 1, 781, 1990.
41. Verma, A., D.J. Hirsch, and S.H. Snyder, Calcium pools mobilized by calcium or inositol 1,4,5-trisphosphate are differentially localized in rat heart and brain, Mol. Biol. Cell., 3, 621, 1992.
42. Cajal, R.Y., Histologie du Systeme Nerveux de l’Homme et des Vertebres, Maloine, Paris, 1911.
43. Johnston, D. and T.H. Brown, Giant synaptic potential hypothesis for epileptiform activity, Science. 211, 294, 1981.
44. Radpour, S. and A.M. Thomson, Coactivation of Local Circuit NMDA Receptor Mediated epsps Induces Lasting Enhancement of Minimal Schaffer Collateral epsps in Slices of Rat Hippocampus, Eur. J. Neurosci., 3, 602, 1991.
45. Johnston, D. and D.G. Amaral, Hippocampus, in The Synaptic Organization of the Brain, G.M. Shepard, Ed., Oxford University Press, New York, 1998, 429.
46. Tamamaki, N., K. Abe, and Y. Nojyo, Columnar organization in the subiculum formed by axon branches originating from single CA1 pyramidal neurons in the rat hippocampus, Brain Res., 412, 156, 1987.
47. Amaral, D.G., C. Dolorfo, and P. Alvarez-Royo, Organization of CA1 projections to the subiculum: a PHA-L analysis in the rat, Hippocampus. 1, 415, 1991.
48. Miles, R. and R.K. Wong, Excitatory synaptic interactions between CA3 neurones in the guinea-pig hippocampus, J. Physiol., 373, 397, 1986.
49. MacVicar, B.A. and F.E. Dudek, Local synaptic circuits in rat hippocampus: interactions between pyramidal cells, Brain Res., 184, 220, 1980.
50. Ishizuka, N., W.M. Cowan, and D.G. Amaral, A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus, J. Comp. Neurol., 362, 17, 1995.
51. Li, X.G., et al., The hippocampal CA3 network: an in vivo intracellular labeling study, J. Comp. Neurol., 339, 181, 1994.
52. Traub, R.D. and R. Miles, Multiple modes of neuronal population activity emerge after modifying specific synapses in a model of the CA3 region of the hippocampus, Ann. N.Y. Acad. Sci., 627, 277, 1991.
53. Johnston, D. and T.H. Brown, The synaptic nature of the paroxysmal depolarizing shift in hippocampal neurons, Ann. Neurol., 16 Suppl., S65, 1984.
54. Johnston, D. and T.H. Brown, Control Theory Applied to Neural Networks Illuminates Synaptic Basis of Interictal Epileptiform Activity, Raven Press, New York, 1986, 263.
55. Johnston, D. and T.H. Brown, Mechanisms of Neuronal Burst Generation, Academic Press, London, 1984, 277.
56. Bruton, C.J., The Neuropathology of Temporal Lobe Epilepsy, Oxford University Press, New York, 1988.
57. Eng, L.F., A.C. Yu, and Y.L. Lee, Astrocytic response to injury, Prog. Brain Res., 94, 353, 1992.
58. Miller, K.K., et al., Localization of an endoplasmic reticulum calcium ATPase mRNA in rat brain by in situ hybridization, Neuroscience. 43, 1, 1991.
59. Korkotian, E., et al., Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons, J. Biol. Chem., 274, 21673, 1999.
60. Gunteski-Hamblin, A.M., J. Greeb, and G.E. Shull, A novel Ca2+ pump expressed in brain, kidney, and stomach is encoded by an alternative transcript of the slowtwitch muscle sarcoplasmic reticulum Ca-ATPase gene. Identification of cDNAs encoding Ca2+ and other cation-transporting ATPases using an oligonucleotide probe derived from the ATP-binding site, J. Biol. Chem., 263, 15032, 1988.
61. Toft, M., et al., Parkinsonism, FXTAS, and FMR1 premutations, Mov. Disord., 20, 230, 2005.
62. Polyak, S.L., The Vertebrate Visual System, University of Chicago Press, Chicago, 1957.
63. Brodemann, K., Vergleichende Lokalisation-slehre der Grosshirnrinde, Barth Press, Leipzig, 1909.
64. Campbell, P.E., et al., A model of neuronopathic Gaucher disease, J. Inherit. Metab. Dis., 26, 629, 2003.
65. Fitzpatrick, D., J.S. Lund, and G.G. Blasdel, Intrinsic connections of macaque striate cortex: afferent and efferent connections of lamina 4C, J. Neurosci., 5, 3329, 1985.
66. Spatz, W.B., Thalamic and other subcortical projections to area MT (visual area of superior temporal sulcus) in the marmoset Callithrix jacchus, Brain Res., 99, 129, 1975.
67. Tigges, J., et al., Areal and laminar distribution of neurons interconnecting the central visual cortical areas 17, 18, 19, and MT in squirrel monkey (Saimiri), J. Comp. Neurol., 202, 539, 1981.
68. Elstein, D., et al., Computerized cognitive testing in patients with type I Gaucher disease: effects of enzyme replacement and substrate reduction, Genet. Med., 7, 124, 2005.
69. Cancilla, P.A., J. Bready, and J. Berliner, Brain endothelial-astrocyte interactions, in The Blood-Brain Barrier: Cellular and Molecular Biology, W.M. Pardridge, Ed., Raven Press, New York, 1993, pp. 25-46.
70. Pardridge, W.M., The blood-brain barrier: bottleneck in brain drug development, NeuroRx. 2, 3, 2005.
71. Pardridge, W.M., The blood-brain barrier and neurotherapeutics, NeuroRx. 2, 1, 2005.
72. Bodennec, J., et al., Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP: phosphocholine cytidylyltransferase by glucosylceramide, Faseb. J., 16, 1814, 2002.
73. Tewes, B.J. and H.J. Galla, Lipid polarity in brain capillary endothelial cells, Endothelium. 8, 207, 2001.